Dublin healthcare services provider UDG Healthcare has filed its first set of accounts since a US private equity firm bought it for €3.2 billion in 2021.
The Dublin-registered unit is no longer a trading entity within the group, having become part of a larger group of healthcare services company under the Inizio banner since the deal late last year.
UDG Healthcare delisted from the London Stock Exchange after US private equity giant Clayton, Dubilier & Rice (CD & R) took it over in a deal valued at £2.6 billion (€3.15 billion) in 2021.
Accounts filed this week by UDG Healthcare this week reveal a more than fourfold increase in profits at the subsidiary in 2021 from €179 million the previous year to more than €791 million last year.
Bellringing for 65 years: ‘It’s great exercise but now that I’m 90 I only ring the lighter ones’
Irish primary schoolchildren have been taught for generations that spring begins on February 1st, but is that true?
‘A lot of things boys seem to instinctually love, we tend to be more dismissive of or even concerned about’
Eli Hewson of Inhaler: ‘There’s so much nepotism in every facet of life’
However, due to the acquisition, 2021 was not an ordinary financial year for the Irish company. It is understood that the dramatic increase in profits is mostly due to an uplift in the value of the companies financial investments in subsidiary undertakings related to CD & R’s takeover of the business.
Before the sale, UDG was concentrated on two businesses: Ashfield, which provided drugmakers with outsourced services such as sales reps and healthcare communications; and Sharp Packaging.
After the takeover Ashfield was integrated with another CD & R-owned company, Huntsworth, to form Inizio. Sharp, meanwhile, was separated from the group last year and is being run independently under the CD & R banner, according to results filed by its ultimate parent, Hunter Holdco, earlier this year.
